ARKG Holdings of Arcturus Therapeutics (ARCT) - Updated Daily
TherapeuticsMessenger RNA
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 2.5% | $714.01m |
| 🏋🏿♂️Weight Rank In ARKG | 🌏Country |
| 16 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 39 | $26.23 |
| 🎫ARK Ownership Percent | |
| 7.17% | |
| Description | |
|---|---|
| founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems. | |
| Website | |
| arcturusrx.com |
Other ETFs That Hold ARCT
Research Notes and Commentary for ARCT
No Research Notes Found for ARCT